AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization Pharmaceutical Investing
BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS Pharmaceutical Investing
U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome Pharmaceutical Investing
Pfizer and Ionis announce discontinuation of vupanorsen clinical development program Pharmaceutical Investing
European Commission Approves LORVIQUA® as a First-Line Treatment for ALK-Positive Advanced Lung Cancer Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory DLBCL, PMBCL and FL3B Pharmaceutical Investing
Merck and Ridgeback's Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies Pharmaceutical Investing
Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
